Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs

Showing results (271-280 of 294) with videos related to

Pageof 30
Sort By:
BMJ Open Sport & Exercise Medicine|February 9, 2023
ELITE: rationale and design of a longitudinal elite athlete, extreme cardiovascular phenotyping, prospective cohort studyJuliette C van Hattum, Sjoerd M Verwijs, S Matthijs Boekholdt, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2022
The Sports Cardiology Team: Personalizing Athlete Care Through a Comprehensive, Multidisciplinary ApproachJuliette C van Hattum, Sjoerd M Verwijs, P Jeff Senden, et al.
European Heart Journal. Cardiovascular Imaging|April 11, 2018
Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imagingWouter P Te Rijdt, Judith N Ten Sande, Thomas M Gorter, et al.
JAMA Cardiology|November 4, 2020
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based StudiesMarios K Georgakis, James A de Lemos, Colby Ayers, et al.
Circulation Research|September 4, 2019
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 IndividualsMarios K Georgakis, Rainer Malik, Harry Björkbacka, et al.
JAMA Cardiology|May 30, 2019
Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve MicrocalcificationNicolas Perrot, Sébastien Thériault, Christian Dina, et al.
JACC. Basic to Translational Science|August 8, 2020
Genetic and In Vitro Inhibition of <i>PCSK9</i> and Calcific Aortic Valve StenosisNicolas Perrot, Vincenza Valerio, Donato Moschetta, et al.
Circulation|July 21, 2010
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibilityMenno Vergeer, S Matthijs Boekholdt, Manjinder S Sandhu, et al.
Circulation|May 19, 2010
PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European AncestryJuan P Casas, Ewa Ninio, Andrie Panayiotou, et al.
Circulation. Cardiovascular Genetics|February 25, 2014
Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levelsMichael V Holmes, Holly J Exeter, Lasse Folkersen, et al.
Pageof 30

Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
BMJ Open Sport & Exercise Medicine|February 9, 2023
ELITE: rationale and design of a longitudinal elite athlete, extreme cardiovascular phenotyping, prospective cohort studyJuliette C van Hattum, Sjoerd M Verwijs, S Matthijs Boekholdt, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2022
The Sports Cardiology Team: Personalizing Athlete Care Through a Comprehensive, Multidisciplinary ApproachJuliette C van Hattum, Sjoerd M Verwijs, P Jeff Senden, et al.
European Heart Journal. Cardiovascular Imaging|April 11, 2018
Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imagingWouter P Te Rijdt, Judith N Ten Sande, Thomas M Gorter, et al.
JAMA Cardiology|November 4, 2020
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based StudiesMarios K Georgakis, James A de Lemos, Colby Ayers, et al.
Circulation Research|September 4, 2019
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 IndividualsMarios K Georgakis, Rainer Malik, Harry Björkbacka, et al.
JAMA Cardiology|May 30, 2019
Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve MicrocalcificationNicolas Perrot, Sébastien Thériault, Christian Dina, et al.
JACC. Basic to Translational Science|August 8, 2020
Genetic and In Vitro Inhibition of <i>PCSK9</i> and Calcific Aortic Valve StenosisNicolas Perrot, Vincenza Valerio, Donato Moschetta, et al.
Circulation|July 21, 2010
Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibilityMenno Vergeer, S Matthijs Boekholdt, Manjinder S Sandhu, et al.
Circulation|May 19, 2010
PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European AncestryJuan P Casas, Ewa Ninio, Andrie Panayiotou, et al.
Circulation. Cardiovascular Genetics|February 25, 2014
Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levelsMichael V Holmes, Holly J Exeter, Lasse Folkersen, et al.
Pageof 30